Incapacitating solar urticaria: successful treatment with omalizumab*
Read
7391
Timeswas read the article
3114
Total PDF
4277
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 10 | 184 | 135 | 319 |
| 2025 9 | 134 | 76 | 210 |
| 2025 8 | 125 | 54 | 179 |
| 2025 7 | 160 | 70 | 230 |
| 2025 6 | 134 | 51 | 185 |
| 2025 5 | 187 | 49 | 236 |
| 2025 4 | 136 | 36 | 172 |
| 2025 3 | 141 | 37 | 178 |
| 2025 2 | 134 | 59 | 193 |
| 2025 1 | 95 | 39 | 134 |
| 2024 12 | 85 | 51 | 136 |
| 2024 11 | 107 | 43 | 150 |
| 2024 10 | 91 | 55 | 146 |
| 2024 9 | 116 | 70 | 186 |
| 2024 8 | 129 | 92 | 221 |
| 2024 7 | 124 | 96 | 220 |
| 2024 6 | 131 | 59 | 190 |
| 2024 5 | 124 | 53 | 177 |
| 2024 4 | 111 | 72 | 183 |
| 2024 3 | 72 | 74 | 146 |
| 2024 2 | 93 | 75 | 168 |
| 2024 1 | 58 | 40 | 98 |
| 2023 12 | 66 | 76 | 142 |
| 2023 11 | 88 | 76 | 164 |
| 2023 10 | 93 | 53 | 146 |
| 2023 9 | 61 | 56 | 117 |
| 2023 8 | 49 | 35 | 84 |
| 2023 7 | 41 | 21 | 62 |
| 2023 6 | 59 | 34 | 93 |
| 2023 5 | 50 | 22 | 72 |
| 2023 4 | 34 | 30 | 64 |
| 2023 3 | 43 | 38 | 81 |
| 2023 2 | 29 | 32 | 61 |
| 2023 1 | 48 | 42 | 90 |
| 2022 12 | 38 | 40 | 78 |
| 2022 11 | 64 | 44 | 108 |
| 2022 10 | 46 | 38 | 84 |
| 2022 9 | 40 | 54 | 94 |
| 2022 8 | 30 | 40 | 70 |
| 2022 7 | 29 | 34 | 63 |
| 2022 6 | 42 | 51 | 93 |
| 2022 5 | 24 | 45 | 69 |
| 2022 4 | 21 | 36 | 57 |
| 2022 3 | 30 | 59 | 89 |
| 2022 2 | 38 | 26 | 64 |
| 2022 1 | 47 | 56 | 103 |
| 2021 12 | 22 | 41 | 63 |
| 2021 11 | 36 | 55 | 91 |
| 2021 10 | 49 | 60 | 109 |
| 2021 9 | 48 | 64 | 112 |
| 2021 8 | 39 | 39 | 78 |
| 2021 7 | 38 | 47 | 85 |
| 2021 6 | 49 | 48 | 97 |
| 2021 5 | 55 | 58 | 113 |
| 2021 4 | 83 | 213 | 296 |
| 2021 3 | 28 | 33 | 61 |
| 2021 2 | 21 | 16 | 37 |
| 2021 1 | 18 | 12 | 30 |
| 2020 12 | 10 | 4 | 14 |
Show all
